Ken Griffin Baxter International Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Baxter International Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 361,900 shares of BAX stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

361,900

Previous 459,300 21.21%

Holding current value

$14 Million

Previous $19.6 Million 38.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$32.87 - $43.55 $93 Million - $123 Million	2,828,051 Added 15709.65%	2,846,053 $95.2 Million
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $6.28 Million - $7.26 Million	-165,905 Reduced 90.21%	18,002 $769,000
Q4 2023 Feb 14, 2024	BUY	$31.71 - $38.95 $548,012 - $673,133	17,282 Added 10.37%	183,907 $7.11 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $132 Million - $175 Million	-3,547,990 Reduced 95.51%	166,625 $6.29 Million
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $46.1 Million - $55 Million	1,153,043 Added 45.01%	3,714,615 $169 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $25.8 Million - $36.1 Million	686,408 Added 36.61%	2,561,572 $104 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $58.8 Million - $68.3 Million	1,183,313 Added 171.04%	1,875,164 $95.6 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $9.63 Million - $11.9 Million	-178,804 Reduced 20.54%	691,851 $37.3 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $10.9 Million - $13.6 Million	-170,342 Reduced 16.36%	870,655 $55.9 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $75.4 Million - $87.7 Million	-980,548 Reduced 48.5%	1,040,997 $80.7 Million
Q4 2021 Feb 14, 2022	BUY	$74.57 - $87.19 $29.7 Million - $34.7 Million	397,887 Added 24.51%	2,021,545 $174 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $91.9 Million - $104 Million	1,245,964 Added 329.89%	1,623,658 $131 Million
Q2 2021 Aug 16, 2021	BUY	$80.5 - $88.01 $26.3 Million - $28.7 Million	326,553 Added 638.53%	377,694 $30.4 Million
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $32.4 Million - $35.4 Million	-430,201 Reduced 89.38%	51,141 $4.1 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $28.3 Million - $32.8 Million	361,834 Added 302.77%	481,342 $38.7 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $326 Million - $391 Million	-4,150,578 Reduced 97.2%	119,508 $10.3 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $88.9 Million - $116 Million	-1,241,714 Reduced 22.53%	4,270,086 $347 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $346 Million - $399 Million	4,511,252 Added 450.88%	5,511,800 $461 Million
Q3 2019 Nov 14, 2019	BUY	$81.4 - $89.78 $4.18 Million - $4.61 Million	51,346 Added 5.41%	1,000,548 $87.5 Million
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $68.3 Million - $76.6 Million	929,635 Added 4751.03%	949,202 $77.7 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $17.4 Million - $22.1 Million	-283,621 Reduced 93.55%	19,567 $1.29 Million
Q3 2018 Nov 13, 2018	SELL	$70.71 - $77.75 $195 Million - $214 Million	-2,753,106 Reduced 90.08%	303,188 $0
Q2 2018 Aug 10, 2018	SELL	$63.43 - $75.41 $97 Million - $115 Million	-1,529,864 Reduced 33.36%	3,056,294 $0
Q1 2018 May 11, 2018	SELL	$62.56 - $72.26 $44.3 Million - $51.2 Million	-708,438 Reduced 13.38%	4,586,158 $298 Million
Q4 2017 Feb 09, 2018	BUY	$61.45 - $66.05 $224 Million - $241 Million	3,652,903 Added 222.51%	5,294,596 $342 Million
Q3 2017 Nov 09, 2017	BUY	$59.5 - $64.61 $97.7 Million - $106 Million	1,641,693	1,641,693 $103 Million

Others Institutions Holding BAX

# of Institutions

981

Shares Held

446M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account